Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06254365
NA

Investigating Glucose Metabolism of LEAP2 With Total-body PET/CT

Sponsor: University Hospital, Gentofte, Copenhagen

View on ClinicalTrials.gov

Summary

The naturally occurring hormone LEAP2 is proposed to have opposite effects to that of the 'hunger hormone' ghrelin. Other that appetite regulation, LEAP2 is involved in glucose metabolism through mechanisms yet not fully understood. With two experimental days; one recieving LEAP2 and one recieving placebo infusion in a randomized order, the study will explore the effect of LEAP2 (vs. placebo) on glucose metabolism through total-body PET/CT-scans and thereby gain a deeper understanding of the ghrelin/LEAP2 system and its interaction with glucose metabolism. Furthermore, the project will generate scanning references in individuals with obesity that are usable in forthcoming research projects.

Official title: Effects of Antagonizing the Ghrelin Receptor on Total-body Glucose Metabolism in Obesity

Key Details

Gender

MALE

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

9

Start Date

2024-02-21

Completion Date

2025-09

Last Updated

2025-06-19

Healthy Volunteers

Yes

Conditions

Interventions

BIOLOGICAL

Exogenous LEAP2 hormone

This intervention has never been examined in this type of study before.

Locations (1)

Center for Clinical Metabolic Research, Gentofte Hospital

Hellerup, Capital Region, Denmark